Münich, Germany

Felix Bohne



Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • München, DE (2018)
  • Münich, DE (2020)
  • Munich, DE (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Felix Bohne: Innovator in Hepatitis B Research**

Introduction

Felix Bohne, an accomplished inventor based in Münich, Germany, has made significant contributions to the field of medical research, particularly in the realm of treatments for Hepatitis B virus (HBV) infections. With three patents to his name, Bohne's work showcases his commitment to advancing healthcare through innovative solutions.

Latest Patents

Bohne's latest patents reflect his focus on HBV infection and its associated conditions. One notable invention is titled "Means and methods for treating HBV infection and associated conditions." This patent introduces a polypeptide that comprises two sets of complementarity determining regions (CDRs) designed to target specific antigens related to HBV. The technology aims to treat or prevent HBV infection and related ailments, such as liver cirrhosis and hepatocellular carcinoma.

Another patent, "Trispecific binding molecules for treating HBV infection and associated conditions," describes a binding molecule with at least three specificities. These include a Hepatitis B surface antigen and signaling molecules crucial for immune response enhancement. This innovative approach not only targets the HBV but also seeks to engage the body’s immune system effectively.

Career Highlights

Felix Bohne has held pivotal roles at various esteemed research institutions. Notably, he has worked at the Deutsches Krebsforschungszentrum and Helmholtz Zentrum München, both of which are renowned for their contributions to cancer research and environmental health. His work at these institutions has facilitated advancements in understanding HBV and its implications on human health.

Collaborations

Throughout his career, Bohne has collaborated with esteemed colleagues, including Ulrike Protzer and Frank Momburg. These partnerships have fostered a rich environment for innovation, allowing for the exchange of ideas and expertise crucial in developing new therapeutic methods.

Conclusion

Felix Bohne is a notable figure in the field of HBV research, demonstrating how innovative thinking can lead to significant medical advancements. Through his patents and collaborative efforts, he continues to contribute to the understanding and treatment of Hepatitis B, embodying the spirit of invention and commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…